General Information of the Compound
Compound ID
CP0326222
Compound Name
[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone
    Show/Hide
Synonyms
((7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone
(R)-(4-(5-Chlorobenzo[d]oxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone
081L192FO9
1030377-33-3
BELSOMRA
C23H23ClN6O2
CHEBI:82698
CHEMBL1083659
MK 4305
MK-4305
MK4305
Suvorexant
Suvorexant (MK-4305)
UNII-081L192FO9
[(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone
    Show/Hide
Structure
Formula
C23H23ClN6O2
Molecular Weight
450.93
Canonical SMILES
C[C@@H]1CCN(CCN1C(=O)c1cc(C)ccc1-n1nccn1)c1nc2cc(Cl)ccc2o1
    Show/Hide
InChI
InChI=1S/C23H23ClN6O2/c1-15-3-5-20(30-25-8-9-26-30)18(13-15)22(31)29-12-11-28(10-7-16(29)2)23-27-19-14-17(24)4-6-21(19)32-23/h3-6,8-9,13-14,16H,7,10-12H2,1-2H3/t16-/m1/s1
    Show/Hide
InChIKey
JYTNQNCOQXFQPK-MRXNPFEDSA-N
CAS
1030377-33-3
Physicochemical Property
logP
4.11132
Rotatable Bonds
3
Heavy Atom Count
32
Polar Areas
80.29
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
7
Complexity
32

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 24965990
SID: 56264110
ChEMBL ID
CHEMBL1083659
DrugBank ID
DB09034
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01132, Orexin receptor type 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  5
1
IC50 = 0.4 nM
   TI
   LI
   LO
   TS
2
IC50 = 56 nM
   TI
   LI
   LO
   TS
3
Ki = 0.35 nM
   TI
   LI
   LO
   TS
4
Ki = 0.4 nM
   TI
   LI
   LO
   TS
5
Ki = 11.8 nM
   TI
   LI
   LO
   TS
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 138 nM
   TI
   LI
   LO
   TS
CL000012 Sf21 Spodoptera frugiperda (Fall armyworm)  1
1
Ki = 0.7943 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 56 nM
2 Ki = 0.4 nM
Protein ID: PT05830, Orexin receptor type 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 8.71 nM
   TI
   LI
   LO
   TS
Protein ID: PT02001, Orexin/Hypocretin receptor type 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  4
1
IC50 = 50 nM
   TI
   LI
   LO
   TS
2
Ki = 0.55 nM
   TI
   LI
   LO
   TS
3
Ki = 0.6 nM
   TI
   LI
   LO
   TS
4
Ki = 3.09 nM
   TI
   LI
   LO
   TS
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 199 nM
   TI
   LI
   LO
   TS
CL000012 Sf21 Spodoptera frugiperda (Fall armyworm)  1
1
Ki = 0.3981 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 50 nM
2 Ki = 0.6 nM
Protein ID: PT05456, Orexin/Hypocretin receptor type 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  1
1
Ki = 1.698 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Suvorexant )
Drug Name Suvorexant
Indication
Insomnia
Approved
Target(s)
Orexin receptor type 2 (HCRTR2)
Modulator